Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Inclusion:
Diagnosed history of asthma
Non smoker last two years
\< 5 pack years
FEV1 \>70% of predicted
Mild and stable asthma
Only using short acting b2-agonist as rescue for the last 4 weeks
Have a history of atopy.
Exclusion:
Any significant respiratory disease, other than asthma
Subjects with seasonal asthma may not be included if they are in their season
Use of oral or inhaled glucocorticosteroid for the last 3 months and long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and antileukotrienes within two weeks
Upper or lower RTI within 6 weeks
Evidence of any disease that in the investigators mind would affect the results of the study
Participating in another study within 4 weeks
Females who are pregnant, intend to be or who are lactating
Methacholine PD20 \> 454mcg
Negative scin prick test
Clareo Health | A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients